Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Paymentus
PAY
$4.29B
| $51.8K | ﹤0.01% |
3,121
+61
| +2% | +$811 |
|
|
SRG
3702
Seritage Growth Properties
SRG
$136M
| $51.8K | ﹤0.01% |
6,691
-369
| -5% | -$3.09K |
|
|
NCTY
3703
The9 Ltd
NCTY
$68.1M
| $51.5K | ﹤0.01% |
7,600
| – | – |
|
|
GBIO
3704
DELISTED
Generation Bio
GBIO
| $51.5K | ﹤0.01% |
1,359
-381
| -22% | -$18K |
|
3705
iShares MSCI Malaysia ETF
EWM
$310M
| $51.5K | ﹤0.01% |
2,500
| – | – |
|
3706
AN2 Therapeutics
ANTX
$193M
| $51K | ﹤0.01% |
3,170
-23,904
| -88% | -$271K |
|
|
OSG
3707
DELISTED
Overseas Shipholding Group Inc.
OSG
| $51K | ﹤0.01% |
11,609
+43
| +0.4% | +$179 |
|
3708
Third Coast Bancshares
TCBX
$729M
| $50.9K | ﹤0.01% |
2,978
-117
| -4% | -$2.19K |
|
3709
Kaltura
KLTR
$206M
| $50.8K | ﹤0.01% |
29,380
-1,679
| -5% | -$3.31K |
|
3710
Puma Biotechnology
PBYI
$404M
| $50.7K | ﹤0.01% |
19,285
+1,945
| +11% | +$6.62K |
|
3711
ThredUp
TDUP
$746M
| $50.6K | ﹤0.01% |
12,611
-1,697
| -12% | -$5.76K |
|
3712
ARK Blockchain & Fintech Innovation ETF
ARKF
$710M
| $50.5K | ﹤0.01% |
2,606
+1,041
| +67% | +$22.1K |
|
3713
iShares Global Consumer Discretionary ETF
RXI
$260M
| $50.4K | ﹤0.01% |
344
-344
| -50% | -$53.2K |
|
3714
Greenlight Captial
GLRE
$552M
| $50.2K | ﹤0.01% |
4,678
-933
| -17% | -$10K |
|
|
SYNH
3715
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $50K | ﹤0.01% |
1,164
-4,663,776
| -100% | -$198M |
|
3716
Park Aerospace
PKE
$737M
| $50K | ﹤0.01% |
3,220
-805
| -20% | -$11.6K |
|
|
TRML
3717
DELISTED
Tourmaline Bio
TRML
| $49.7K | ﹤0.01% |
1,770
+1,065
| +151% | +$31.2K |
|
3718
Carter Bankshares
CARE
$766M
| $49.5K | ﹤0.01% |
3,947
-1,103
| -22% | -$15.8K |
|
3719
Chemung Financial Corp
CHMG
$393M
| $49.4K | ﹤0.01% |
1,246
-204
| -14% | -$8.2K |
|
3720
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $49.3K | ﹤0.01% |
1,060
-221
| -17% | -$11.4K |
|
3721
Comscore
SCOR
$106M
| $49.2K | ﹤0.01% |
4,011
| – | – |
|
3722
Limoneira
LMNR
$235M
| $49.2K | ﹤0.01% |
3,212
-306
| -9% | -$4.67K |
|
3723
Bitdeer Technologies
BTDR
$2.56B
| $49.2K | ﹤0.01% |
+5,100
| New | +$60.7K |
|
3724
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
| $49K | ﹤0.01% |
250
| – | – |
|
|
RPTX
3725
DELISTED
Repare Therapeutics
RPTX
| $49K | ﹤0.01% |
4,054
+645
| +19% | +$6.66K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.